We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Beats Stock Market Upswing: What Investors Need to Know
Read MoreHide Full Article
In the latest trading session, UnitedHealth Group (UNH - Free Report) closed at $319.97, marking a +2.71% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.98%. Meanwhile, the Dow gained 1.08%, and the Nasdaq, a tech-heavy index, added 0.88%.
The largest U.S. health insurer's shares have seen a decrease of 13.57% over the last month, not keeping up with the Medical sector's gain of 4.76% and the S&P 500's loss of 2.79%.
Investors will be eagerly watching for the performance of UnitedHealth Group in its upcoming earnings disclosure. The company's upcoming EPS is projected at $2.07, signifying a 69.60% drop compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $113.53 billion, showing a 12.62% escalation compared to the year-ago quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $16.29 per share and a revenue of $447.97 billion, indicating changes of -41.11% and +11.91%, respectively, from the former year.
Investors should also take note of any recent adjustments to analyst estimates for UnitedHealth Group. Recent revisions tend to reflect the latest near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.66% higher. UnitedHealth Group presently features a Zacks Rank of #3 (Hold).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 19.13. For comparison, its industry has an average Forward P/E of 11.81, which means UnitedHealth Group is trading at a premium to the group.
We can additionally observe that UNH currently boasts a PEG ratio of 2.03. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - HMOs industry currently had an average PEG ratio of 1.16 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 203, placing it within the bottom 18% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, UnitedHealth Group (UNH - Free Report) closed at $319.97, marking a +2.71% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.98%. Meanwhile, the Dow gained 1.08%, and the Nasdaq, a tech-heavy index, added 0.88%.
The largest U.S. health insurer's shares have seen a decrease of 13.57% over the last month, not keeping up with the Medical sector's gain of 4.76% and the S&P 500's loss of 2.79%.
Investors will be eagerly watching for the performance of UnitedHealth Group in its upcoming earnings disclosure. The company's upcoming EPS is projected at $2.07, signifying a 69.60% drop compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $113.53 billion, showing a 12.62% escalation compared to the year-ago quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $16.29 per share and a revenue of $447.97 billion, indicating changes of -41.11% and +11.91%, respectively, from the former year.
Investors should also take note of any recent adjustments to analyst estimates for UnitedHealth Group. Recent revisions tend to reflect the latest near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.66% higher. UnitedHealth Group presently features a Zacks Rank of #3 (Hold).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 19.13. For comparison, its industry has an average Forward P/E of 11.81, which means UnitedHealth Group is trading at a premium to the group.
We can additionally observe that UNH currently boasts a PEG ratio of 2.03. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - HMOs industry currently had an average PEG ratio of 1.16 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 203, placing it within the bottom 18% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.